Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Inogen Inc (INGN)

Inogen Inc (INGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 169,675
  • Shares Outstanding, K 27,148
  • Annual Sales, $ 335,710 K
  • Annual Income, $ -35,890 K
  • EBIT $ -32 M
  • EBITDA $ -11 M
  • 60-Month Beta 1.76
  • Price/Sales 0.46
  • Price/Cash Flow N/A
  • Price/Book 0.88

Options Overview Details

View History
  • Implied Volatility 114.43% (+10.24%)
  • Historical Volatility 50.36%
  • IV Percentile 94%
  • IV Rank 64.14%
  • IV High 152.15% on 01/12/26
  • IV Low 46.96% on 08/14/25
  • Expected Move (DTE 33) 1.49 (23.80%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 8
  • Volume Avg (30-Day) 125
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 813
  • Open Int (30-Day) 754
  • Expected Range 4.76 to 7.74

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.31
  • Number of Estimates 1
  • High Estimate -0.31
  • Low Estimate -0.31
  • Prior Year -0.41
  • Growth Rate Est. (year over year) +24.39%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.00 +4.17%
on 01/12/26
7.46 -16.22%
on 01/07/26
-0.56 (-8.22%)
since 12/16/25
3-Month
6.00 +4.17%
on 01/12/26
9.13 -31.54%
on 10/22/25
-2.26 (-26.56%)
since 10/16/25
52-Week
5.70 +9.65%
on 05/15/25
12.91 -51.59%
on 01/30/25
-4.27 (-40.59%)
since 01/16/25

Most Recent Stories

More News
Inogen Announces Preliminary Revenue Results for Fourth Quarter and Full-Year 2025

Inogen to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

INGN : 6.25 (-3.10%)
Inogen Announces the Launch of Aurora CPAP Masks for Obstructive Sleep Apnea in the United States

Expansion Aligns with Innovation and Growth Strategy

INGN : 6.25 (-3.10%)
Inogen: Q3 Earnings Snapshot

Inogen: Q3 Earnings Snapshot

INGN : 6.25 (-3.10%)
Inogen Announces Third Quarter 2025 Financial Results

Delivered seventh consecutive quarter of mid-single-digit revenue growth Reiterating full-year revenue guidance

INGN : 6.25 (-3.10%)
Inogen to Report Third Quarter 2025 Financial Results on November 5, 2025

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report third quarter...

INGN : 6.25 (-3.10%)
Inogen Announces the Appointment of Naga Rameswamy as Chief Technology Officer

Inogen, Inc. (Nasdaq: INGN ), a leading medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Naga...

INGN : 6.25 (-3.10%)
3 Top Medical Instruments Stocks Defying Tariff Pressure With GenAI

Over the past year, the Medical Instruments industry has seen the transition of generative AI (genAI) from experimental to operational, reshaping diagnostics, patient monitoring and intervention workflows....

ITGR : 85.78 (+0.59%)
TFX : 103.00 (-1.54%)
INGN : 6.25 (-3.10%)
Inogen: Q2 Earnings Snapshot

Inogen: Q2 Earnings Snapshot

INGN : 6.25 (-3.10%)
Inogen Announces Second Quarter 2025 Financial Results

Delivered strong top-line results; raising full year 2025 revenue expectations

INGN : 6.25 (-3.10%)
Inogen to Report Second Quarter 2025 Financial Results on August 7, 2025

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report second quarter...

INGN : 6.25 (-3.10%)

Business Summary

Inogen Inc. develops, manufactures and markets POC. POCs are used by patients who suffer from chronic respiratory conditions and need long-term oxygen therapy. POCs concentrate the air around the patient, filter out the nitrogen and other unwanted substances and deliver oxygen. The company provides oxygen...

See More

Key Turning Points

3rd Resistance Point 6.58
2nd Resistance Point 6.50
1st Resistance Point 6.38
Last Price 6.25
1st Support Level 6.18
2nd Support Level 6.10
3rd Support Level 5.98

See More

52-Week High 12.91
Fibonacci 61.8% 10.16
Fibonacci 50% 9.31
Fibonacci 38.2% 8.45
Last Price 6.25
52-Week Low 5.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar